InsiderTrades

Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC

Accepted 2022-05-04 00:00:00 ET · period of report 2022-04-29 · accession 0001567619-22-009494 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-05-04 2022-04-29 BMRN Davis George Eric EVP, CLO A - Grant $62.41 +341 66.3K +0.5% +$21.3K
D 2022-05-04 2022-05-02 BMRN Davis George Eric EVP, CLO S - Sale+OE $80.38 -15.3K 66.3K -19% -$1.23M
D 2022-05-04 2022-05-02 BMRN Davis George Eric EVP, CLO M - OptEx $37.46 +15.3K 81.7K +23% +$574.9K
D 2022-05-04 2022-05-02 BMRN Davis George Eric EVP, CLO M - OptEx $0.00 -15.3K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-04-29 A A 341 $62.41 66,339 D — — (F1) Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan.
2 Common Common Stock 2022-05-02 S D 15,347 $80.38 66,339 D — — (F2) Trade made pursuant to a 10b5-1 plan executed on March 4, 2022.
3 Common Common Stock 2022-05-02 M A 15,347 $37.46 81,686 D — — (F2) Trade made pursuant to a 10b5-1 plan executed on March 4, 2022.
4 Derivative Stock Option (Right to buy Common Stock) 2022-05-02 M D 15,347 $0.00 0 D $37.46 · 2012-11-08 to 2022-05-07 15,347 Common Stock (F2) Trade made pursuant to a 10b5-1 plan executed on March 4, 2022. (F3) Reflects the number of options outstanding after the transactions from this specific stock option grant.